Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to staphylococcal PVE risk post-valve replacement; leaves open relevance of these rates to contemporary prophylaxis and surgery.
Prosthetic valve endocarditis is an infrequent but serious complication of valve surgery. It occurred in 25 (3.2%) of 772 patients who received aortic, mitral or double valve replacement in 1971-1987. The total follow-up time was 3,976 patient years, giving an incidence of 0.63/100 patient years. Staphylococci were the most common of the cultured organisms in early and late infections-60% and 64%, respectively. The endocarditis was disclosed at autopsy in two cases. Treatment was antibiotics alone in 11 cases, and surgery was required in 12, the indication always being congestive heart failure. C-reactive protein level fell more rapidly than erythrocyte sedimentation rate in response to antibiotic or surgical management. The mortality rate was 73% in the antibiotic group and 33% in the surgical group. The findings demonstrated that an infected valve prosthesis should be replaced without delay if complications develop.
No takes yet. Share an insight, caveat, or question.
Janatuinen et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: